In a young adult population, pharmacologic prophylaxis initiated within 24 hours was associated with lower incidence of venous thromboembolic events without increasing bleeding.
In a prospective, controlled study, patients who were vaccinated before discharge from hospitalization for acute heart failure had fewer all-cause deaths and hospital readmissions.